3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
4
Pathologic Complete Response
2
Multiple Myeloma
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Melanoma
1
Colorectal Neoplasms
1
Interventions
daratumumab
2
siltuximab
1
sargramostim
1
elotuzumab
1
PVX-410 vaccine
1
Monatide (IMS 3015)
1
Lenalidomide
1
IPH-2101
1
Emulsions
1
BHQ880
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Smoldering Multiple Myeloma
×
Monatide (IMS 3015)
×
Clear all
NCT02240537
2016-04-19
BBMPI03
Benovus Bio, Inc.
Phase 1
Unknown
4 enrolled